Allakos Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ALLK on Nasdaq
Industry
Pharmaceutical Preparations
Location
825 Industrial Road, Suite 500, San Carlos, CA

Insiders trading volume in the past year

Allakos Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Janney Director $22.6M May 25, 2023
Bvf Partners L P/Il 10%+ Owner $2.14M Jan 16, 2024
Craig A. Paterson Chief Medical Officer $809K Dec 4, 2023
Mark Asbury CLO, GC and Secretary $567K Mar 2, 2022
Margaret Nell Fitzgerald General Counsel and Secretary $383K Sep 2, 2022
Chin Hyok Lee Chief Medical Officer $311K Dec 4, 2024
Robert Alexander Chief Executive Officer, Director $275K Mar 6, 2025
Henrik Rasmussen Chief Medical Officer $252K Jun 3, 2021
Adam Tomasi President $139K Mar 5, 2025
Baird Radford Chief Financial Officer $42.5K -$87.9K -67.4% Mar 5, 2025
Ladd Amy L Director May 24, 2024
Natalie Holles Director May 25, 2021
Steven P. James Director May 24, 2024
Neil Murray Hamilton Graham Director May 24, 2024
Everett Rand Sutherland Director Aug 1, 2023
Robert E. Andreatta Director May 24, 2024
Paul Edward Walker Director May 24, 2024
John P. Mckearn Director May 25, 2022
Alta Partners Management VIII, LLC 10%+ Owner Aug 16, 2023
Dolca Thomas Director May 24, 2024

Recent Insider Transactions by Companies or Individuals for Allakos Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.